Skip to content
ppharmaranks
Menu

LIORESAL vs LYVISPAH

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Rating

70/100
70/100

Pharmacy pays

~$1.55 /30
~$1.55 /30

Type

RX
RX

Active ingredient

BACLOFEN
BACLOFEN

Dosage forms

Injectable, Tablet
Powder

Drug class

Gamma-Aminobutyric Acid-Ergic Agonist
Gamma-Aminobutyric Acid-Ergic Agonist

Boxed warning

None
None

Half-life

about 5.7 hours
about 5.7 hours

Treats

Neurogenic Urinary Bladder, Cerebral Palsy, Hiccup
Neurogenic Urinary Bladder, Cerebral Palsy, Hiccup

Frequently asked questions

Which is better-rated, Lioresal or Lyvispah?

Lioresal and Lyvispah are tied at 3.5 out of 5 by our independent rating.

Which is cheaper, Lioresal or Lyvispah?

Pharmacies pay about the same to acquire either one — roughly $1.55 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Lioresal and Lyvispah?

Both Lioresal and Lyvispah share the active ingredient Baclofen.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.